|
1
|
Cavero I and Guillon JM: Safety
Pharmacology assessment of drugs with biased 5-HT(2B) receptor
agonism mediating cardiac valvulopathy. J Pharmacol Toxicol
Methods. 69:150–161. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nombela-Franco L, Eltchaninoff H, Zahn R,
Testa L, Leon MB, Trillo-Nouche R, D'Onofrio A, Smith CR, Webb J,
Bleiziffer S, et al: Clinical impact and evolution of mitral
regurgitation following transcatheter aortic valve replacement: A
meta-analysis. Heart. 101:1395–1405. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Gurbuz O, Kumtepe G, Yolgosteren A, Ozkan
H, Karal IH, Ercan A and Ener S: A comparison of off- and on-pump
beating-heart coronary artery bypass surgery on long-term
cardiovascular events. Cardiovasc J Afr. 27:12016.PubMed/NCBI
|
|
4
|
Willemsen RT, Buntinx F, Winkens B, Glatz
JF and Dinant GJ: ‘RAPIDA’-study team: The value of signs, symptoms
and plasma heart-type fatty acid-binding protein (H-FABP) in
evaluating patients presenting with symptoms possibly matching
acute coronary syndrome: Background and methods of a diagnostic
study in primary care. BMC Fam Pract. 15:2032014. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Patro N, Naik A and Patro IK: Differential
temporal expression of S100β in developing rat brain. Front Cell
Neurosci. 9:87–99. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Tomasi R and Dossow-Hanfstingl VV:
Analgesie-, sedierungs- und delir- management auf der
intensivstation. Intensiv- und Notfallbehandlung. 39:167–172.
2015.(In German). View
Article : Google Scholar
|
|
7
|
Whitlock RP, Devereaux PJ, Teoh KH, Lamy
A, Vincent J, Pogue J, Paparella D, Sessler DI, Karthikeyan G,
Villar JC, et al: SIRS Investigators: Methylprednisolone in
patients undergoing cardiopulmonary bypass (SIRS): A randomised,
double-blind, placebo-controlled trial. Lancet. 386:1243–1253.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sigaut S, Tremey B, Ouattara A, Couturier
R, Taberlet C, Grassin-Delyle S, Dreyfus JF, Schlumberger S and
Fischler M: Comparison of two doses of tranexamic acid in adults
undergoing cardiac surgery with cardiopulmonary bypass.
Anesthesiology. 120:590–600. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Howard BT, Iles TL, Coles JA, Sigg DC and
Iaizzo PA: Reversible and irreversible damage of the myocardium:
Ischemia/reperfusion injury and cardioprotectionHandbook of Cardiac
Anatomy, Physiology, and Devices. 3rd edition. Springer
International Publishing; pp. 279–293. 2015, View Article : Google Scholar
|
|
10
|
Green JS and Tsui BC: Impact of anesthesia
for cancer surgery: Continuing Professional Development. Can J
Anaesth. 60:1248–1269. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Kiliç K, Hanci V, Selek S, Sözmen M, Kiliç
N, Citil M, Yurtlu DA and Yurtlu BS: The effects of dexmedetomidine
on mesenteric arterial occlusion-associated gut ischemia and
reperfusion-induced gut and kidney injury in rabbits. J Surg Res.
178:223–232. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Jung SM and Cho CK: The effects of deep
and light propofol anesthesia on stress response in patients
undergoing open lung surgery: A randomized controlled trial. Korean
J Anesthesiol. 68:224–231. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Bell MT, Agoston VA, Freeman KA, Puskas F,
Herson PS, Mares J, Fullerton DA and Reece TB: Interruption of
spinal cord microglial signaling by alpha-2 agonist dexmedetomidine
in a murine model of delayed paraplegia. J Vasc Surg. 59:1090–1097.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Glatz JF and Renneberg R: Added value of
H-FABP as plasma biomarker for the early evaluation of suspected
acute coronary syndrome. Clin Lipidol. 9:205–220. 2014. View Article : Google Scholar
|
|
15
|
Banning A, Musumeci F, Penny W and Tovey
JA: Reference intervals for cardiac troponin T, creatine kinase and
creatine kinase-MB isoenzyme following coronary bypass graft
surgery. Ann Clin Biochem. 33:561–562. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Sandoval Y, Smith SW, Schulz KM, Murakami
MM, Love SA, Nicholson J and Apple FS: Diagnosis of type 1 and type
2 myocardial infarction using a high-sensitivity cardiac troponin I
assay with sex-specific 99th percentiles based on the third
universal definition of myocardial infarction classification
system. Clin Chem. 61:657–663. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Funai Y, Pickering AE, Uta D, Nishikawa K,
Mori T, Asada A, Imoto K and Furue H: Systemic dexmedetomidine
augments inhibitory synaptic transmission in the superficial dorsal
horn through activation of descending noradrenergic control: An in
vivo patch-clamp analysis of analgesic mechanisms. Pain.
155:617–628. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Pfeifer R, Franz M and Figulla HR:
Hypothermia after cardiac arrest does not affect serum levels of
neuron-specific enolase and protein S-100b. Acta Anaesthesiol
Scand. 58:1093–1100. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Benedict C, Cedernaes J, Giedraitis V,
Nilsson EK, Hogenkamp PS, Vågesjö E, Massena S, Pettersson U,
Christoffersson G, Phillipson M, et al: Acute sleep deprivation
increases serum levels of neuron-specific enolase (NSE) and S100
calcium binding protein B (S-100B) in healthy young men. Sleep.
37:195–198. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Sun L, Guo R and Sun L: Dexmedetomidine
for preventing sevoflurane-related emergence agitation in children:
A meta-analysis of randomized controlled trials. Acta Anaesthesiol
Scand. 58:642–650. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Chen S, Hua F, Lu J, Jiang Y, Tang Y, Tao
L, Zou B and Wu Q: Effect of dexmedetomidine on myocardial
ischemia-reperfusion injury. Int J Clin Exp Med. 8:21166–21172.
2015.PubMed/NCBI
|
